Allogenic stem cell therapy has emerged as a promising approach in regenerative medicine, offering potential treatments for a variety of diseases through the use of stem cells derived from donors. This review examines the current landscape of allogenic stem cell therapy, highlighting significant progress and ongoing challenges. We explore various types of stem cell treatments, including hematopoietic stem cell transplantation and mesenchymal stem cell therapies, and assess the status of clinical trials worldwide. The review discusses advancements in clinical outcomes, the hurdles faced in terms of immunogenicity, graft-versus-host disease (GVHD), and ethical concerns. Finally, we outline future directions for research and clinical practice, emphasizing the need for improved techniques and novel strategies to enhance the efficacy and safety of allogenic stem cell therapies.
